These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3234490)

  • 1. Receptor reserve at striatal dopamine receptors modulating the release of [3H]dopamine.
    Yokoo H; Goldstein M; Meller E
    Eur J Pharmacol; 1988 Oct; 155(3):323-7. PubMed ID: 3234490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor reserve at striatal dopamine autoreceptors: implications for selectivity of dopamine agonists.
    Meller E; Helmer-Matyjek E; Bohmaker K; Adler CH; Friedhoff AJ; Goldstein M
    Eur J Pharmacol; 1986 Apr; 123(2):311-4. PubMed ID: 3709668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between receptor occupancy and response at striatal dopamine autoreceptors.
    Meller E; Bohmaker K; Namba Y; Friedhoff AJ; Goldstein M
    Mol Pharmacol; 1987 Jun; 31(6):592-8. PubMed ID: 2885734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of receptor reserve at striatal dopamine receptors regulating cholinergic neuronal activity.
    Meller E; Enz A; Goldstein M
    Eur J Pharmacol; 1988 Oct; 155(1-2):151-4. PubMed ID: 2907486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible receptor inactivation reveals differences in dopamine receptor reserve between A9 and A10 dopamine systems: an electrophysiological analysis.
    Cox RF; Waszczak BL
    Brain Res; 1990 Nov; 534(1-2):273-82. PubMed ID: 1981482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in dopamine receptor reserve for N-n-propylnorapomorphine enantiomers: single unit recording studies after partial inactivation of receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Cox RF; Waszczak BL
    Mol Pharmacol; 1989 Jan; 35(1):125-31. PubMed ID: 2563304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
    Tedford CE; Crosby G; Iorio LC; Chipkin RE
    Eur J Pharmacol; 1992 Feb; 211(2):169-76. PubMed ID: 1535318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine agonist-induced elevation of striatal acetylcholine: relationship between receptor occupancy and response in normal and denervated rat striatum.
    Enz A; Goldstein M; Meller E
    Mol Pharmacol; 1990 Apr; 37(4):560-5. PubMed ID: 1970116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of (-)-sulpiride-induced increase in electrically-evoked release of dopamine from rat striatal slices.
    Yamada S; Yokoo H; Nishi S
    J Pharm Pharmacol; 1993 May; 45(5):479-81. PubMed ID: 8099971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regulation of (-)-sulpiride-induced increase in evoked dopamine release from striatal slices in rat].
    Yamada S; Yokoo H; Nishi S
    Yakubutsu Seishin Kodo; 1992 Aug; 12(4):193-7. PubMed ID: 1414037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of receptor reserve in D1 agonistic action of (-)-stepholidine in lesioned rats.
    Zou LL; Liu J; Jin GZ
    Biochem Pharmacol; 1997 Jul; 54(2):233-40. PubMed ID: 9271327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of substantia nigra dopamine cell firing by R(-)-N-n-propylnorapomorphine: electrophysiological and autoradiographic studies after regional inactivation of dopamine receptors by microinjection of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Cox RF; Waszczak BL
    Brain Res; 1993 Jun; 613(1):32-42. PubMed ID: 8102308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of aging on recovery of striatal dopamine receptors following N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ) blockade.
    Henry JM; Roth GS
    Life Sci; 1984 Aug; 35(8):899-904. PubMed ID: 6482680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The neuroleptic-like peptide desenkephalin-gamma-endorphin does not antagonize the dopamine receptor agonist-induced inhibition of the release of [3H]dopamine from rat nucleus accumbens slices in vitro.
    Radhakishun FS; Stoof JC; Mulder AH; Versteeg DH; van Ree JM
    Brain Res; 1987 Nov; 426(2):235-42. PubMed ID: 2961411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkylation of striatal dopamine receptors abolishes stereotyped behavior but has no effect on dopamine stimulated adenylate cyclase activity.
    Cameron DL; Crocker AD
    Neurosci Lett; 1988 Jul; 90(1-2):165-71. PubMed ID: 3045699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional damage of dopamine nerve terminals following intrastriatal kainic acid injection.
    Bonanno G; Fedele E; Versace P; Raiteri M
    Brain Res; 1989 Feb; 480(1-2):242-8. PubMed ID: 2713653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localization of striatal dopamine receptor function by central injection of an irreversible receptor antagonist.
    Cameron DL; Crocker AD
    Neuroscience; 1989; 32(3):769-78. PubMed ID: 2601845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists.
    Giorgi O; Biggio G
    Brain Res; 1990 Nov; 533(1):53-9. PubMed ID: 1982234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EEDQ, a tool for ex vivo measurement of occupancy of D-1 and D-2 dopamine receptors.
    Nowak G; Arnt J; Hyttel J
    Eur J Pharmacol; 1988 Aug; 153(2-3):309-11. PubMed ID: 3053212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of pertussis toxin on dopamine D2 and serotonin 5-HT1A autoreceptor-mediated inhibition of neurotransmitter synthesis: relationship to receptor reserve.
    Bohmaker K; Bordi F; Meller E
    Neuropharmacology; 1992 May; 31(5):451-9. PubMed ID: 1356248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.